Why Healthcare Market Research Is Different From Consumer Research
By DeltaMV Insights TeamReviewed by DeltaMV Academy EditorialUpdated 5 min read
Module 1 · 2 of 10Foundations of Healthcare Market ResearchAll articles
- What Is Market Research, Really? A Beginner’s Map of the Field
- Why Healthcare Market Research Is Different From Consumer Research
- A Short History: How Pharma & Healthcare Market Research Evolved
- Ethics, Compliance & Data Privacy in Healthcare Market Research
- Types of Healthcare Market Research Studies: Trackers, Ad Hoc, Syndicated & Custom
- How a Market Research Project Actually Runs
- Qualitative vs Quantitative Research
- Primary vs Secondary Research
- Who’s Who: The Healthcare Ecosystem
- Common Myths About Market Research
Healthcare market research differs from consumer research mainly in who gets the final say. A doctor’s judgement, and often an insurer’s approval, can override what a patient wants, something no shop can do to an ordinary customer. People are also grouped differently: by diagnosis, not by taste or budget. And more is at stake if the research gets it wrong.
Key Takeaways
- Similar journeys, different decision-makers. Both consumer and healthcare journeys can be complex and non-linear, but patients’ choices are often shaped by physicians and payers.
- Healthcare segmentation goes beyond diagnosis. Research considers HCPs, patients, and payers across dimensions such as treatment adoption, journey stage, and motivations.
- Stricter regulations and higher stakes. Healthcare research requires greater attention to privacy, consent, compliance, and potential impacts on patient outcomes.
- Same research methods, different context. Healthcare and consumer research use similar tools, but healthcare demands a deeper understanding of stakeholders, decision-making, and constraints.
At a Glance: Consumer vs. Healthcare Research
| Dimension | Consumer Research | Healthcare Research |
|---|---|---|
| Who decides | The buyer decides alone | A doctor, and often an insurer, can say no even if the patient wants it |
| Regulation | Light-touch (privacy laws, ad standards) | Heavy (data privacy, promotional compliance, off-label rules, ethics review) |
| Decision stakes | Often reversible, low-cost mistakes | Can affect treatment access and patient outcomes |
| How people are grouped | By what they want or need | By multiple dimensions: treatment adoption, stage of journey, and motivations – not diagnosis alone |
| Shape of the journey | Loops back and forth before buying | Loops back and forth just as much, not actually different |
| Access to respondents | Relatively easy (general population) | Harder. Physicians’ time is scarce, and patients may be unwell or vulnerable. |
What’s Actually the Same
Strip away who’s involved, and the tools are the same. Both fields talk to people one-on-one to understand why they do something, and both run surveys to measure how many people do it. The shape of the journey is the same too. Many people assume a shopper’s path is messy and a patient’s path is a straight line from diagnosis to treatment. DeltaMV’s own research says otherwise. Map how someone decides to buy a skincare product, or how someone decides on health insurance, and you see the same back and forth, the same pausing, the same circling before anyone commits. Healthcare doesn’t get a straight line either.
Where People Get Confused
The most common mistake is assuming the patient is the only one who decides, the way a shopper is. They often aren’t. A doctor’s judgement, or an insurer’s rules, can change what actually happens next. A second mistake is assuming a patient’s path to treatment is simple and straight, when in practice it loops and stalls just as much as any shopper’s path. A third mistake is running patient research exactly like a regular consumer survey, without extra care for how tired or vulnerable someone might be, or for getting their proper consent.
When the Differences Actually Matter
- Screener design: healthcare screeners need to ask about diagnosis, how long someone has had a condition, and what treatments they’ve tried, not just basic things like age or budget.
- Discussion guide writing: guides have to remember the patient isn’t the only one deciding, and they have to follow stricter rules than a normal consumer guide.
- Patient recruitment: extra care is needed around consent and timing. For example, you wouldn’t approach someone right after they’ve been diagnosed.
- Reading the data: what a patient wants and what a doctor or insurer actually allows can be two very different things, in a way a simple shopping decision never has to deal with.
The Cheat Sheet
Same tools, different people holding the final say. Healthcare research uses the same methods as consumer research. The real difference is that the person you’re talking to often isn’t the one who makes the final call, and people are grouped by diagnosis instead of taste. That’s the whole difference, not how messy their journey looks.
A DeltaMV Perspective
DeltaMV recently mapped the path to adult pneumococcal vaccination in Vietnam using the Hankins Hexagon, a model originally developed by James Hankins (published via WARC, 2021) that DeltaMV adapted to plot the path to vaccination across six stages, from no disease awareness through to vaccinated, connected by feedback loops rather than a single straight line.
The study found that only 3% of the eligible population had been vaccinated, while a further 77% were aware but hadn’t acted. Mapping that 77% onto the hexagon showed the gap wasn’t uniform: roughly a third were stuck at passive assimilation, having absorbed information without a trigger strong enough to move them further; another third had a trigger and were actively comparing options but kept circling without deciding; a smaller group kept receiving triggers from multiple sources without any converting into real evaluation at all.
The group closest to a decision, people already evaluating, was also the cheapest to convert, yet was getting comparatively little direct outreach. Reallocating budget toward closing out people already mid-evaluation, rather than generating more awareness in a population that was already 77% aware, is exactly the kind of move a straight-line funnel view would never surface.
Composite/anonymized example; not a specific client or study.
FAQ
Are the research methods actually different in healthcare?
Not really. Surveys, interviews, and background research are the same tools used in consumer research. What changes is who you’re studying, who else can say no to their decision, and the rules around asking. One exception: traditional focus groups tend to work less well in healthcare, since patients and HCPs are often reluctant to discuss sensitive conditions candidly in a group setting. One-on-one interviews are usually a better starting point.
Why is recruiting physicians harder than recruiting consumers?
Physicians have limited free time, are often bound by their institution’s policies on participating in market research, and need to be compensated within compliance-approved limits. All of that narrows the pool and slows recruitment.
Does healthcare market research need ethics approval like clinical research does?
Not usually in the same formal way as clinical trials, but reputable studies still follow strict privacy, consent, and compliance standards, especially when patients are involved.
Can I use a consumer research agency for healthcare projects?
You can, but look for someone with healthcare or pharma experience. The difference isn’t the method, it’s judgement: knowing the person you’re interviewing might not be the one who decides, building the right sample, and reading answers shaped by rules and professional pressure.
The Bottom Line
Healthcare market research and consumer research use the same basic tools, and both follow journeys that loop rather than run in a straight line. The real differences are who actually gets the final say, how people are grouped, and how much regulation and risk sit on top of the decision. Get those three things right, and the rest looks a lot like research anywhere else.